Business Context and Reporting Period
Company: SANUWAVE Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 3, 2017
Reporting Period: The filing reports on the initial closing of a securities offering that began on March 27, 2017, and concluded on November 3, 2017.
Key Financial Metrics and Capital Structure
This filing details a debt financing event rather than operational financial performance. Key metrics include:
- Debt Issued: $1,124,440 aggregate principal amount of 10% Convertible Promissory Notes issued at the initial closing.
- Interest Rate: 10% annual interest.
- Term: Six months from the subscription date.
- Conversion Price: $0.11 per share of Common Stock.
- Warrants Issued: 10,222,180 Class N Warrants issued in connection with the notes.
- Warrant Exercise Price: $0.11 per share.
- Warrant Expiration: March 17, 2019.
- Use of Proceeds: Working capital and general corporate purposes.
Note: The filing does not provide data on revenue, profit, cash flow, margins, or existing liquidity positions.
Material Changes and Related Party Transactions
The primary material change is the entry into definitive agreements for the issuance of convertible debt and warrants. A significant related party transaction occurred during this offering:
- Related Party Purchase: Premier Shockwave Inc., owned by Anthony Michael Stolarski (a member of the Board of Directors and existing shareholder), purchased $330,000 of the 10% Convertible Promissory Notes.
- Registration Rights: The Company entered into a Registration Rights Agreement requiring the filing of a registration statement for shares issuable upon conversion or warrant exercise. Failure to meet deadlines may result in monetary penalties.
Guidance, Outlook, and Risks
Forward-Looking Statements: The filing contains forward-looking statements regarding projected growth, future revenue, and anticipated improvements in earnings. These are subject to risks and uncertainties.
Risks and Contingencies:
- Registration Deadlines: The Company faces potential monetary penalties if it fails to satisfy deadlines under the Registration Rights Agreement.
- Market Risks: Actual results may differ materially from projections due to factors discussed in the Company's Annual Report on Form 10-K.
- Exemption Reliance: The offering was conducted under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D, exempt from registration, with no general solicitation.
Investor Verification Checklist
- Verify the Company's ability to meet the registration statement deadlines outlined in the Registration Rights Agreement to avoid penalties.
- Confirm the dilution impact of the 10,222,180 Class N Warrants and the potential conversion of $1,124,440 in notes at the $0.11 strike price.
- Review the related party transaction involving Premier Shockwave Inc. to ensure full disclosure of conflicts of interest.
- Assess the Company's current cash position and burn rate to determine if the $1.12 million in proceeds is sufficient for the stated working capital needs.
- Examine the full text of the 10% Convertible Promissory Notes (Exhibit 10.1) for specific default provisions and interest accrual details.